$BCYC
BICYCLE THERAPEUTICS PLC

2024 Q3 Form 10-Q Financial Statement

#000155837024014004 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $2.676M
YoY Change -50.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $17.94M
YoY Change 15.21%
% of Gross Profit
Research & Development $48.27M
YoY Change 21.06%
% of Gross Profit
Depreciation & Amortization $2.172M
YoY Change 27.76%
% of Gross Profit
Operating Expenses $66.52M
YoY Change 18.47%
Operating Profit -$63.85M
YoY Change 25.69%
Interest Expense $10.23M
YoY Change 1156.88%
% of Operating Profit
Other Income/Expense, Net $9.596M
YoY Change 202.62%
Pretax Income -$54.25M
YoY Change 13.91%
Income Tax -$3.400M
% Of Pretax Income
Net Earnings -$50.80M
YoY Change 1.8%
Net Earnings / Revenue -1898.36%
Basic Earnings Per Share -$0.74
Diluted Earnings Per Share -$0.74
COMMON SHARES
Basic Shares Outstanding 68.99M
Diluted Shares Outstanding 68.99M

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $890.9M
YoY Change 55.72%
Cash & Equivalents $890.9M
Short-Term Investments
Other Short-Term Assets $17.35M
YoY Change 26.64%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $966.2M
YoY Change 60.22%
LONG-TERM ASSETS
Property, Plant & Equipment $11.52M
YoY Change -26.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.940M
YoY Change 82.35%
Total Long-Term Assets $30.55M
YoY Change -14.29%
TOTAL ASSETS
Total Short-Term Assets $966.2M
Total Long-Term Assets $30.55M
Total Assets $996.7M
YoY Change 56.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.714M
YoY Change -32.72%
Accrued Expenses $39.31M
YoY Change 15.45%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $182.0K
YoY Change
Total Short-Term Liabilities $56.41M
YoY Change -19.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change -100.0%
Other Long-Term Liabilities $5.963M
YoY Change 38.16%
Total Long-Term Liabilities $5.963M
YoY Change -82.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.41M
Total Long-Term Liabilities $5.963M
Total Liabilities $165.7M
YoY Change -25.58%
SHAREHOLDERS EQUITY
Retained Earnings -$628.9M
YoY Change 35.92%
Common Stock $890.0K
YoY Change 61.82%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $831.0M
YoY Change
Total Liabilities & Shareholders Equity $996.7M
YoY Change 56.06%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$50.80M
YoY Change 1.8%
Depreciation, Depletion And Amortization $2.172M
YoY Change 27.76%
Cash From Operating Activities -$39.83M
YoY Change 3805.1%
INVESTING ACTIVITIES
Capital Expenditures $435.0K
YoY Change -13.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$435.0K
YoY Change -13.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $31.90M
YoY Change
Cash From Financing Activities -31.93M
YoY Change -113.61%
NET CHANGE
Cash From Operating Activities -39.83M
Cash From Investing Activities -435.0K
Cash From Financing Activities -31.93M
Net Change In Cash -72.20M
YoY Change -130.97%
FREE CASH FLOW
Cash From Operating Activities -$39.83M
Capital Expenditures $435.0K
Free Cash Flow -$40.27M
YoY Change 2549.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
dei Entity Central Index Key
EntityCentralIndexKey
0001761612
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2023Q4 us-gaap Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List
FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentNet
CY2024Q3 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2024Q3 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2024Q3 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38916
dei Entity Registrant Name
EntityRegistrantName
Bicycle Therapeutics plc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
X0
dei Entity Address Address Line1
EntityAddressAddressLine1
Blocks A & B, Portway Building, Granta Park
dei Entity Address City Or Town
EntityAddressCityOrTown
Great Abington, Cambridge,
dei Entity Address Country
EntityAddressCountry
GB
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
CB21 6GS
dei City Area Code
CityAreaCode
+44
dei Local Phone Number
LocalPhoneNumber
1223 261503
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
890862000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
526423000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17350000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11406000
CY2024Q3 bcyc Research And Development Incentives Receivable Current
ResearchAndDevelopmentIncentivesReceivableCurrent
57982000
CY2023Q4 bcyc Research And Development Incentives Receivable Current
ResearchAndDevelopmentIncentivesReceivableCurrent
24039000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
966194000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
561868000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11520000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14515000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9092000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13169000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9940000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5792000
CY2024Q3 us-gaap Assets
Assets
996746000
CY2023Q4 us-gaap Assets
Assets
595344000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5714000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13050000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39313000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31509000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11378000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
24978000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
56405000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
69537000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30698000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5533000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9382000
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
97813000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
110216000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5963000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4579000
CY2024Q3 us-gaap Liabilities
Liabilities
165714000
CY2023Q4 us-gaap Liabilities
Liabilities
224412000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
155878645
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
59612613
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69015971
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
69015971
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42431766
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42431766
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
890000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
550000
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1462264000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
883446000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3185000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1304000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-628937000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-511760000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
831032000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
370932000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
996746000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
595344000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2676000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5352000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31567000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21645000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48265000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39868000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
123188000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
111799000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18257000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16281000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50588000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45557000
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
66522000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
56149000
us-gaap Operating Expenses
OperatingExpenses
173776000
us-gaap Operating Expenses
OperatingExpenses
157356000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-63846000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-50797000
us-gaap Operating Income Loss
OperatingIncomeLoss
-142209000
us-gaap Operating Income Loss
OperatingIncomeLoss
-135711000
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
10583000
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
3985000
us-gaap Interest And Other Income
InterestAndOtherIncome
23981000
us-gaap Interest And Other Income
InterestAndOtherIncome
7726000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
33000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
814000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1678000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2443000
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-954000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-954000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9596000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3171000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
21349000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5283000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-54250000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47626000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-120860000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-130428000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3448000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2272000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3683000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1137000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-50802000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49898000
us-gaap Net Income Loss
NetIncomeLoss
-117177000
us-gaap Net Income Loss
NetIncomeLoss
-131565000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.95
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68988858
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68988858
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39576467
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39576467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54566490
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54566490
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33291701
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
792000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
664000
us-gaap Operating Lease Payments
OperatingLeasePayments
4333000
us-gaap Operating Lease Payments
OperatingLeasePayments
4188000
bcyc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
9000
bcyc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-1689000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3898000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1102000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-50800000
us-gaap Net Income Loss
NetIncomeLoss
-117200000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49900000
us-gaap Net Income Loss
NetIncomeLoss
-131600000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-628900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition, the accrual for research and development expenses and research and development incentives receivable, share-based compensation expense, valuation of right-of-use assets and liabilities and income taxes, including the valuation allowance for deferred tax assets. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of reasonable changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates or assumptions.</p>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33291701
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-50802000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49898000
us-gaap Net Income Loss
NetIncomeLoss
-117177000
us-gaap Net Income Loss
NetIncomeLoss
-131565000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2093000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3762000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1881000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
2498000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52895000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46136000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-119058000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-129067000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
370932000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1870000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9282000
CY2024Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
526000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-26563000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
356048000
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4500000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
11400000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
544127000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9264000
CY2024Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-314000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-39812000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
873813000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
912000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9202000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-2093000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-50802000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
831032000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
270783000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
100000
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2716000
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9042000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-316000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-39064000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
243163000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
165000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
400000
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
12127000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8193000
CY2023Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-948000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-42603000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
220097000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
139000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
15500000
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
234492000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7430000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3762000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49898000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
416022000
us-gaap Profit Loss
ProfitLoss
-117177000
us-gaap Profit Loss
ProfitLoss
-131565000
us-gaap Share Based Compensation
ShareBasedCompensation
27748000
us-gaap Share Based Compensation
ShareBasedCompensation
24665000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5470000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4892000
bcyc Non Cash Interest Expense
NonCashInterestExpense
211000
bcyc Non Cash Interest Expense
NonCashInterestExpense
289000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-954000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4192000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
3588000
us-gaap Other Noncash Expense
OtherNoncashExpense
1036000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2482000
bcyc Increase Decrease In Research And Development Incentives Receivable
IncreaseDecreaseInResearchAndDevelopmentIncentivesReceivable
31107000
bcyc Increase Decrease In Research And Development Incentives Receivable
IncreaseDecreaseInResearchAndDevelopmentIncentivesReceivable
-2192000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5244000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4615000
bcyc Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-3326000
bcyc Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-3116000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7593000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3835000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
5952000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
6084000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3626000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2983000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-31275000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
74238000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
189000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
442000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-155328000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13340000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
867000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2878000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-867000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2878000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31863000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
544127000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
249335000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7283000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
306000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
519547000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
249641000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1087000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
364439000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
233480000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
526970000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
339154000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
891409000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
572634000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
890862000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
572086000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
547000
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
548000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
891409000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
572634000
us-gaap Interest Paid Net
InterestPaidNet
1373000
us-gaap Interest Paid Net
InterestPaidNet
2059000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
792000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
664000
us-gaap Operating Lease Payments
OperatingLeasePayments
4333000
us-gaap Operating Lease Payments
OperatingLeasePayments
4188000
bcyc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
9000
bcyc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-1689000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3898000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
1102000
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
890900000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-50800000
us-gaap Net Income Loss
NetIncomeLoss
-117200000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49900000
us-gaap Net Income Loss
NetIncomeLoss
-131600000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-628900000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of estimates </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting periods. Significant estimates and assumptions reflected in these condensed consolidated financial statements include, but are not limited to, revenue recognition, the accrual for research and development expenses and research and development incentives receivable, share-based compensation expense, valuation of right-of-use assets and liabilities and income taxes, including the valuation allowance for deferred tax assets. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. Estimates are periodically reviewed in light of reasonable changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates or assumptions.</p>
CY2024Q3 bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
8500000
bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
31100000
CY2023Q3 bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
5000000.0
bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
17600000
CY2024Q3 bcyc Research And Development Incentives Receivable Current
ResearchAndDevelopmentIncentivesReceivableCurrent
58000000.0
CY2024Q4 bcyc Research And Development Incentives Received
ResearchAndDevelopmentIncentivesReceived
31700000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
500000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
500000
CY2024Q3 bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
8500000
bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
31100000
CY2023Q3 bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
5000000.0
bcyc Reduction Of Research And Development Expense
ReductionOfResearchAndDevelopmentExpense
17600000
CY2024Q3 bcyc Research And Development Incentives Receivable Current
ResearchAndDevelopmentIncentivesReceivableCurrent
58000000.0
CY2024Q4 bcyc Research And Development Incentives Received
ResearchAndDevelopmentIncentivesReceived
31700000
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
500000
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
500000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1102000
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
31255000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
27908000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
13393000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14515000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2200000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5500000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1700000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4900000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12981000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13394000
CY2024Q3 bcyc Accrued External Research And Development Expenses
AccruedExternalResearchAndDevelopmentExpenses
18640000
CY2023Q4 bcyc Accrued External Research And Development Expenses
AccruedExternalResearchAndDevelopmentExpenses
11839000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1739000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1143000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5372000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4876000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
182000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
399000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
257000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39313000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31509000
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
1900000
CY2024Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
900000
CY2024Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1000000.0
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
1102000
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
31255000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
27908000
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
19735000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
13393000
CY2024Q3 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
11520000
CY2023Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
14515000
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2200000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5500000
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1700000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4900000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12981000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
13394000
CY2024Q3 bcyc Accrued External Research And Development Expenses
AccruedExternalResearchAndDevelopmentExpenses
18640000
CY2023Q4 bcyc Accrued External Research And Development Expenses
AccruedExternalResearchAndDevelopmentExpenses
11839000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1739000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1143000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5372000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4876000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
182000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
399000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
257000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39313000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
31509000
CY2024Q3 us-gaap Restructuring Charges
RestructuringCharges
1900000
CY2024Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
900000
CY2024Q3 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
1000000.0
CY2020Q3 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0455
CY2020Q3 bcyc Debt Instrument End Of Term Charge Rate
DebtInstrumentEndOfTermChargeRate
0.050
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000.0
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
100000
CY2024Q3 bcyc Debt End Of Term Charge
DebtEndOfTermCharge
1500000
CY2024Q3 bcyc Debt Instrument Prepayment Charges
DebtInstrumentPrepaymentCharges
300000
CY2024Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31900000
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000.0
CY2020Q3 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0455
CY2020Q3 bcyc Debt Instrument End Of Term Charge Rate
DebtInstrumentEndOfTermChargeRate
0.050
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000.0
CY2024Q3 us-gaap Interest Payable Current
InterestPayableCurrent
100000
CY2024Q3 bcyc Debt End Of Term Charge
DebtEndOfTermCharge
1500000
CY2024Q3 bcyc Debt Instrument Prepayment Charges
DebtInstrumentPrepaymentCharges
300000
CY2024Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
31900000
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1000000.0
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2023Q4 bcyc Debt End Of Term Charge
DebtEndOfTermCharge
946000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
248000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
30698000
bcyc Number Of Vote Per Share
NumberOfVotePerShare
1
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
155878645
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
59612613
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9202000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7430000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27748000
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
30000000
CY2023Q4 bcyc Debt End Of Term Charge
DebtEndOfTermCharge
946000
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
30698000
bcyc Number Of Vote Per Share
NumberOfVotePerShare
1
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
155878645
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
59612613
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9202000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7430000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27748000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24665000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2676000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5352000
bcyc Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
328000
bcyc Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
31567000
bcyc Contract With Customer Liability Foreign Currency Adjustment
ContractWithCustomerLiabilityForeignCurrencyAdjustment
-5236000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
109191000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
61873000
CY2023 bcyc Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
95960000
CY2023 bcyc Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
26976000
CY2023 bcyc Contract With Customer Liability Foreign Currency Adjustment
ContractWithCustomerLiabilityForeignCurrencyAdjustment
-4337000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
135194000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2024Q3 bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
2676000
CY2023Q3 bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
5006000
bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
21126000
bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
13829000
CY2023Q3 bcyc Contract With Customer Liability Revenue Recognized Expiration Of Material Rights
ContractWithCustomerLiabilityRevenueRecognizedExpirationOfMaterialRights
346000
bcyc Contract With Customer Liability Revenue Recognized Expiration Of Material Rights
ContractWithCustomerLiabilityRevenueRecognizedExpirationOfMaterialRights
10576000
bcyc Contract With Customer Liability Revenue Recognized Expiration Of Material Rights
ContractWithCustomerLiabilityRevenueRecognizedExpirationOfMaterialRights
7816000
bcyc Contract With Customer Liability Revenue Recognized Changes In Transaction Price
ContractWithCustomerLiabilityRevenueRecognizedChangesInTransactionPrice
-135000
CY2024Q3 bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
2676000
CY2023Q3 bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
5352000
bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
31567000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2676000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5352000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
31567000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21645000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
135194000
bcyc Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
328000
bcyc Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
31567000
bcyc Contract With Customer Liability Foreign Currency Adjustment
ContractWithCustomerLiabilityForeignCurrencyAdjustment
-5236000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
109191000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
61873000
CY2023 bcyc Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
95960000
CY2023 bcyc Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
26976000
CY2023 bcyc Contract With Customer Liability Foreign Currency Adjustment
ContractWithCustomerLiabilityForeignCurrencyAdjustment
-4337000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
135194000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
0
CY2024Q3 bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
2676000
CY2023Q3 bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
5006000
bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
21126000
bcyc Contract With Customer Liability Revenue Recognized Proportional Performance Obligation
ContractWithCustomerLiabilityRevenueRecognizedProportionalPerformanceObligation
13829000
CY2023Q3 bcyc Contract With Customer Liability Revenue Recognized Expiration Of Material Rights
ContractWithCustomerLiabilityRevenueRecognizedExpirationOfMaterialRights
346000
bcyc Contract With Customer Liability Revenue Recognized Expiration Of Material Rights
ContractWithCustomerLiabilityRevenueRecognizedExpirationOfMaterialRights
10576000
bcyc Contract With Customer Liability Revenue Recognized Expiration Of Material Rights
ContractWithCustomerLiabilityRevenueRecognizedExpirationOfMaterialRights
7816000
bcyc Contract With Customer Liability Revenue Recognized Changes In Transaction Price
ContractWithCustomerLiabilityRevenueRecognizedChangesInTransactionPrice
-135000
CY2024Q3 bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
2676000
CY2023Q3 bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
5352000
bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
31567000
CY2016Q4 bcyc Research And Development Arrangement Obligation To Repay Other Parties
ResearchAndDevelopmentArrangementObligationToRepayOtherParties
50900000
CY2019Q4 bcyc Research And Development Arrangement Obligation To Repay Other Parties
ResearchAndDevelopmentArrangementObligationToRepayOtherParties
60300000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3400000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2024Q3 bcyc Incremental Income Tax Benefit On Completion Of Research And Development Tax Credit Study
IncrementalIncomeTaxBenefitOnCompletionOfResearchAndDevelopmentTaxCreditStudy
3500000
CY2024Q3 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
2400000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1100000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1100000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1355000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1364000
us-gaap Operating Lease Cost
OperatingLeaseCost
4034000
us-gaap Operating Lease Cost
OperatingLeaseCost
4057000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
760000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
566000
us-gaap Variable Lease Cost
VariableLeaseCost
2104000
us-gaap Variable Lease Cost
VariableLeaseCost
2017000
CY2024Q3 us-gaap Lease Cost
LeaseCost
2115000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1930000
us-gaap Lease Cost
LeaseCost
6138000
us-gaap Lease Cost
LeaseCost
6074000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.078
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1481000
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
69000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6005000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
273000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3456000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
273000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
821000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
273000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
273000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
205000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
858000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
264000
bcyc Total Revenue Recognized From Both Beginning Balance And Current Period Increase In Contract Liability
TotalRevenueRecognizedFromBothBeginningBalanceAndCurrentPeriodIncreaseInContractLiability
21645000
CY2016Q4 bcyc Research And Development Arrangement Obligation To Repay Other Parties
ResearchAndDevelopmentArrangementObligationToRepayOtherParties
50900000
CY2019Q4 bcyc Research And Development Arrangement Obligation To Repay Other Parties
ResearchAndDevelopmentArrangementObligationToRepayOtherParties
60300000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3400000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3700000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000
CY2024Q3 bcyc Incremental Income Tax Benefit On Completion Of Research And Development Tax Credit Study
IncrementalIncomeTaxBenefitOnCompletionOfResearchAndDevelopmentTaxCreditStudy
3500000
CY2024Q3 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
2400000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1100000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1100000
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1355000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1364000
us-gaap Operating Lease Cost
OperatingLeaseCost
4034000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
760000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
566000
us-gaap Variable Lease Cost
VariableLeaseCost
2104000
us-gaap Variable Lease Cost
VariableLeaseCost
2017000
CY2024Q3 us-gaap Lease Cost
LeaseCost
2115000
CY2023Q3 us-gaap Lease Cost
LeaseCost
1930000
us-gaap Lease Cost
LeaseCost
6138000
us-gaap Lease Cost
LeaseCost
6074000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M12D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.078
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.095
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1481000
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
69000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6005000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
273000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3456000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
273000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
821000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
273000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
273000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
205000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
858000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
264000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10905000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1102000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5372000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
182000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5533000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
920000
bcyc Maximum Days Allowed For Cancellation Of Contracts Prior Written Notice
MaximumDaysAllowedForCancellationOfContractsPriorWrittenNotice
P90D
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50802000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49898000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-117177000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-131565000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68988858
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68988858
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39576467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54566490
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33291701
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
10905000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
1102000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5372000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
182000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5533000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
920000
bcyc Maximum Days Allowed For Cancellation Of Contracts Prior Written Notice
MaximumDaysAllowedForCancellationOfContractsPriorWrittenNotice
P90D
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-50802000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-49898000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-117177000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-131565000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
68988858
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68988858
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
39576467
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
39576467
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54566490
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54566490
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33291701
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33291701
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.95
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9669327
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7647124
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.26
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.95
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9669327
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7647124
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
20612000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
27684000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
20612000
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
27684000

Files In Submission

Name View Source Status
0001558370-24-014004-index-headers.html Edgar Link pending
0001558370-24-014004-index.html Edgar Link pending
0001558370-24-014004.txt Edgar Link pending
0001558370-24-014004-xbrl.zip Edgar Link pending
bcyc-20240930.xsd Edgar Link pending
bcyc-20240930x10q.htm Edgar Link pending
bcyc-20240930xex31d1.htm Edgar Link pending
bcyc-20240930xex31d2.htm Edgar Link pending
bcyc-20240930xex32d1.htm Edgar Link pending
bcyc-20240930_cal.xml Edgar Link unprocessable
bcyc-20240930_def.xml Edgar Link unprocessable
bcyc-20240930x10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
bcyc-20240930_pre.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bcyc-20240930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable